Relationship between ILD induced by EGFR-TKI and MUC4 genetic polymorphism in patients harboring EGFR mutations - NEJ022 Study, a case-control study within a cohort
Not Applicable
- Conditions
- non-small cell lung cancer harboring EGFR mutations
- Registration Number
- JPRN-UMIN000015612
- Lead Sponsor
- orth East Japan Study Group (NEJSG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
1)Having drug allergy for EGFR-TKI 2)Pregnant woman, having possibility of pregnancy, or lactating woman 3)Having the other causes of contraindication for EGFR-TKI 4)In addition, the primary doctor judging inappropriate for entry
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of Odds ratios of occurring ILDs between patients with or without MUC4 genetic polymorphisms
- Secondary Outcome Measures
Name Time Method To detect risk factors of ILD by multivariate analyses, which are decided before calculating data